Publications

The oncologist

Critical appraisal of translational research models for suitability in performance assessment of cancer centers.

25-12-2012

European journal of radiology

Reducing the throughput time of the diagnostic track involving CT scanning with computer simulation.

01-11-2012

BMC research notes

Scenario drafting to anticipate future developments in technology assessment.

16-08-2012

BMC health services research

Exploring improvements in patient logistics in Dutch hospitals with a survey.

01-08-2012

BMC medical informatics and decision making

A review on the relation between simulation and improvement in hospitals.

14-03-2012

Breast cancer research and treatment

Head-to-head comparison of the 70-gene signature versus the 21-gene assay: cost-effectiveness and the effect of compliance.

01-01-2012

BMC cancer

A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.

03-11-2011

BMC cancer

Design of the Physical exercise during Adjuvant Chemotherapy Effectiveness Study (PACES): a randomized controlled trial to evaluate effectiveness and cost-effectiveness of physical exercise in improving physical fitness and reducing fatigue.

07-12-2010

BMC health services research

International benchmarking of specialty hospitals. A series of case studies on comprehensive cancer centres.

31-08-2010

European journal of cancer (Oxford, England : 1990)

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.

01-05-2010

Molecular oncology

Benchmarking biology research organizations using a new, dedicated tool.

01-02-2010

Molecular oncology

Review on early technology assessments of nanotechnologies in oncology.

01-12-2009

European journal of cancer (Oxford, England : 1990)

Improving the efficiency of a chemotherapy day unit: applying a business approach to oncology.

01-03-2009

International journal of technology assessment in health care

Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.

01-01-2009

Tumori

Early phase Technology Assessment of nanotechnology in oncology.

21-06-2008

The Lancet. Oncology

Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER).

01-12-2007

Journal of health organization and management

Strategic behaviour of institutional providers in mental handicapped care in the Netherlands.

24-08-2007